Company news

Canntab Therapeutics Limited news in 2018

Canntab Therapeutics Limited's news releases, calls and decks from 2018, newest first.

View company

InvestmentPitch Media Video Discusses Canntab Therapeutics and its Application to Become a Licensed Producer Under ACMPR with Health Canada - Video News Alert on Investmentpitch.com

October 22, 2018

Canntab Files Application to Become Licensed Producer

October 18, 2018

Canntab Therapeutics, Extended Release Cannabis Tablets, CEO Clip Video

October 4, 2018

InvestmentPitch Media Video Discusses Canntab Therapeutics LOI With NewCanna of Colombia to Distribute Canntab Products in Select Countries - Video News Alert on Investmentpitch.com

October 4, 2018

Canntab Enters LOI for Bi-Lateral Sales & Distribution and Cannabis Oil Supply

October 1, 2018

Canntab Added to CSE Composite Index

September 24, 2018

Canntab Sets New All-Time High Trading Prices and Volume

September 20, 2018

Canntab Exceeds All-Time High Trading Prices and Grants Options

September 19, 2018

Canntab and Emblem Announce Positive Results on Testing: Proceeding to Clinical Trials

September 18, 2018

Canntab Signs Collaboration and Profit Sharing Agreement with FSD Pharma for Production and Market of Oral Dose Delivery Platforms

September 18, 2018

Canntab Engages Industry Leader Lorne Gertner as Consultant

July 16, 2018

InvestmentPitch Media Video Discusses Canntab Therapeutics LOI with FSD Pharma to Obtain License to Process and Sell Cannabis Based Products - Video News Alert on Investmentpitch.com

July 11, 2018

Canntab announces collaboration and profit sharing agreement with FSD Pharma to produce and market oral dose delivery platforms

July 9, 2018

Canntab Announces Launch of Innovative Hemp Oil Capsules

June 20, 2018

Canntab Announces Director Resignation

June 14, 2018

Canntab Therapeutics Files 2 New Canadian Patent Applications Related to Pharmaceutical Cannabis

May 25, 2018

Canntab Appoints Bob Woloschuk to Advisory Board

May 17, 2018

Canntab Provides Clarification on CFN Media Engagement

May 15, 2018

Emblem and Canntab Therapeutics Announce Health Canada Approval for R&D of Cannabinoid-Based Oral Sustained Release Formulation

May 14, 2018

Canntab Therapeutics Files 11 Patent Applications Related to Pharmaceutical Cannabis

April 26, 2018

Canntab Provides Corporate Update

April 24, 2018